Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
CXApp Inc.CXApp Inc. Reports 36% Revenue Decline, Focuses on AI-Powered SaaS Model
SANGAMO THERAPEUTICS, INCSangamo Therapeutics Reports $122.9 Million Net Loss in 2025 Amid Strategic Shift
Jasper Therapeutics, Inc.Jasper Therapeutics Reports $75.8 Million Net Loss for Fiscal Year 2025, Focuses on Mast Cell Disease Programs
Domtar CORPDomtar Corporation Reports $804 Million Net Loss for Fiscal Year 2025
Kochav Defense Acquisition Corp.Kochav Defense Acquisition Corp. Reports $5.5 Million Net Income for Fiscal Year 2025
Seneca Bancorp, Inc.Seneca Bancorp Reports $172,000 Net Income for Fiscal Year 2025, Down 75.8%
Terns Pharmaceuticals, Inc.Terns Pharmaceuticals Reports $96.2 Million Net Loss for 2025, Merger with Merck Announced
60 DEGREES PHARMACEUTICALS, INC.60 Degrees Pharmaceuticals Reports 65.5% Revenue Increase to $1.01 Million for Fiscal Year 2025
Rising Dragon Acquisition Corp.Rising Dragon Acquisition Corp. Reports $1.57 Million Net Income for Fiscal Year 2025
Wright Investors Service Holdings, Inc.Wright Investors' Service Reports Increased Net Loss and Weakened Financial Position for Fiscal Year 2025
Ainos, Inc.Ainos, Inc. Reports 499% Revenue Growth to $124,157 in 2025 Fiscal Year
Translational Development Acquisition Corp.Translational Development Acquisition Corp. Reports $6.4M Net Income for Fiscal Year 2025
Oxley Bridge Acquisition LtdOxley Bridge Acquisition Limited Reports $4.8M Net Income for Fiscal Year 2025
Bicara Therapeutics Inc.Bicara Therapeutics Reports $138M Net Loss and Business Updates in Annual Filing
Annexon, Inc.Annexon Reports $206.7 Million Net Loss for 2025, Driven by Increased Operating Expenses
Transportation & Logistics Systems, Inc.Transportation and Logistics Systems Reports Net Income Turnaround Amid Operational Challenges
NewHydrogen, Inc.NewHydrogen Reports $2.8 Million Net Loss for Fiscal Year 2025 Amid Rising Operational Expenses
MILLERKNOLL, INC.MillerKnoll Reports 5.8% Revenue Growth and Net Earnings Recovery in Q3 Fiscal 2026
ONCOLYTICS BIOTECH INCOncolytics Biotech Reports $28.8 Million Net Loss and Strategic Transition to Nevada
INTELLINETICS, INC.Intellinetics Reports $16.6 Million Revenue for Fiscal Year 2025, 8% Decrease from 2024
Trailblazer Acquisition Corp.Trailblazer Acquisition Corp. Reports Financial Performance for Fiscal Year Ending December 31, 2025
Allarity Therapeutics, Inc.Allarity Therapeutics Reports $11.2 Million Net Loss, First Revenue from Drug Response Predictor
CVD EQUIPMENT CORPCVD Equipment Corporation Reports $25.8 Million Revenue for Fiscal Year 2025, Down 4.1%
Inmune Bio, Inc.INmune Bio Reports $45.9 Million Net Loss for Fiscal Year 2025
EXOZYMES INC.eXoZymes Reports 56.3% Increase in Operating Loss for Fiscal Year 2025